Table of Contents Table of Contents
Previous Page  18 / 23 Next Page
Information
Show Menu
Previous Page 18 / 23 Next Page
Page Background

Avelumab: Adverse Events > 10% patients, Part A, 2L

Kaufman HL, et al. Lancet Oncol. 2016;17(10):1374-85; Kaufman. AACR 2017

1 … 12 13 14 15 16 17 18 19 20 21 22 23  FlippingBook